| Ginseng, garlic, gingko biloba. The market for 'alternative' herbal
medicine is booming, with herbal remedies now stocking store shelves from Marks
& Spencer to Wal-Mart. But as botanical cures hit the commercial mainstream,
suspicions are growing about their real benefits. New analysis of the impacts of
the exploitation of herbal and traditional medicines is finding that organic is
not automatically ecologically or socially better, though people often assume it
is. Herbal medicines are credited with helping to relieve a host of ailments
from depression (Saint John's wort) to cancer (essiac tea) to lack of energy
(ginseng). By providing a low-tech answer to pharmaceutical drugs, the market
has benefited from an image of being more 'home-grown' and personal than the
normal corporate fare. Not surprisingly, then, world sales of herbal remedies
are increasing by more than 10% a year, according to a recent study from the UK
consulting firm McAlpine, Thorpe and Warner. China and Indonesia are among the
biggest suppliers, with sales of Chinese traditional medicines alone shooting up
by 113% between 1990 and 1994. Commercial success, yes, but ecological success?
The thriving trade is now being singled out for putting some plants in danger of
over-exploitation and extinction. Already, the study says, eighteen species
could be wiped out unless urgent action is taken. The endangered medicinal
plants with the largest international markets include Chinese ginseng
with 8,000 tonnes traded a year and gingko biloba from the maidenhair
tree with 3,000 tonnes traded. Chinese officials are finding it difficult
to regulate their large, fragmented industry, which involves about 13,000
farmers and 1,500 firms. Of about 389 rare and endangered species in the
country, 77 are normally used in Chinese traditional medicine. Of another 1,000
commonly used medicinal plants, about 800 are gathered directly from the wild,
laying open the possibility for further over-exploitation in future years. The
social impacts of traditional medicine can also be alarming, when the
traditional medicinal knowledge of indigenous peoples is exploited without a
fair sharing of commercial gains. Unfortunately, high-minded companies like San
Francisco-based Shaman Pharmaceuticals or the pharmaceutical giant Merck in
Costa Rica which pride themselves on equitable dealings with tropical
countries and traditional healers are still the exception rather than the
rule. The growing international demand for Chinese and other traditional
medicines carries both opportunity and alarm. Low-tech and home-grown, these
remedies provide cheap and effective medicine for a growing number of people.
But the inter-linkages between medicinal treatment, trade and environmental
impact cannot be ignored. The situation presents a major challenge for
decision-makers in companies, governments and international bodies like the
World Trade Organization: Can the trend toward increased international trade in
herbal medicine grow to accommodate rising concerns about its ecological and
social impact? |